Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 10
2003 10
2004 19
2005 11
2006 10
2007 12
2008 20
2009 28
2010 27
2011 35
2012 28
2013 36
2014 42
2015 42
2016 53
2017 61
2018 67
2019 75
2020 102
2021 109
2022 134
2023 135
2024 157
2025 175
2026 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,308 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis.
Wang X, Wu X, Tan B, Zhu L, Zhang Y, Lin L, Xiao Y, Sun A, Wan X, Liu S, Liu Y, Ta N, Zhang H, Song J, Li T, Zhou L, Yin J, Ye L, Lu H, Hong J, Cheng H, Wang P, Li W, Chen J, Zhang J, Luo J, Huang M, Guo L, Pan X, Jin Y, Ye W, Dai L, Zhu J, Sun L, Zheng B, Li D, He Y, Liu M, Wu H, Du B, Xu H. Wang X, et al. Among authors: zhou l. Cell. 2024 Sep 5;187(18):4890-4904.e9. doi: 10.1016/j.cell.2024.06.027. Epub 2024 Jul 15. Cell. 2024. PMID: 39013470 Free article. Clinical Trial.
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis.
Wang X, Zhang Y, Jin Y, Dai L, Yue Y, Hu J, Liu X, Pang K, Ye S, Chen Y, Ye W, Shi X, Ma X, Guo L, Liu Y, Ta N, Zhu X, Lin L, Wang J, Yan R, Wang P, Song X, Zhou Y, Zhou L, Wang Q, Guan T, Li T, Zhou L, Pan W, He Y, Wu X, Xu Y, Yang L, Xu H. Wang X, et al. Among authors: zhou l. Cell. 2025 Aug 7;188(16):4225-4238.e12. doi: 10.1016/j.cell.2025.05.038. Epub 2025 Jun 24. Cell. 2025. PMID: 40562027
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity.
Huang Y, Zhong WQ, Yang XY, Shan JL, Zhou L, Li ZL, Guo YQ, Zhang KM, Du T, Zhang HL, Hu BX, Chen YH, Yang D, Feng GK, Tang J, Zhu XF, Deng R. Huang Y, et al. Among authors: zhou l. Nat Commun. 2025 Apr 14;16(1):3546. doi: 10.1038/s41467-025-58740-3. Nat Commun. 2025. PMID: 40229277 Free PMC article.
Deep insight into cytokine storm: from pathogenesis to treatment.
Nie J, Zhou L, Tian W, Liu X, Yang L, Yang X, Zhang Y, Wei S, Wang DW, Wei J. Nie J, et al. Among authors: zhou l. Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y. Signal Transduct Target Ther. 2025. PMID: 40234407 Free PMC article. Review.
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.
Sun C, Kang YF, Fang XY, Liu YN, Bu GL, Wang AJ, Li Y, Zhu QY, Zhang H, Xie C, Kong XW, Peng YJ, Lin WJ, Zhou L, Chen XC, Lu ZZ, Xu HQ, Hong DC, Zhang X, Zhong L, Feng GK, Zeng YX, Xu M, Zhong Q, Liu Z, Zeng MS. Sun C, et al. Among authors: zhou l. Cell Host Microbe. 2023 Nov 8;31(11):1882-1897.e10. doi: 10.1016/j.chom.2023.09.011. Epub 2023 Oct 16. Cell Host Microbe. 2023. PMID: 37848029 Free article.
Immunopathogenesis and immunomodulatory therapy for myocarditis.
He W, Zhou L, Xu K, Li H, Wang JJ, Chen C, Wang D. He W, et al. Among authors: zhou l. Sci China Life Sci. 2023 Sep;66(9):2112-2137. doi: 10.1007/s11427-022-2273-3. Epub 2023 Mar 29. Sci China Life Sci. 2023. PMID: 37002488 Free PMC article. Review.
1,308 results